Angeles Equity Partners has sold Xanitos Inc., a provider of healthcare environmental services, to Bessemer Investors, marking a significant transaction fueled by substantial growth and strategic alignment.
Target Overview
Angeles Equity Partners, LLC, a prominent private investment firm, has successfully completed the sale of Xanitos Inc. to an affiliate of Bessemer Investors, LLC. The financial details of the transaction remain undisclosed. Xanitos is recognized for providing essential healthcare environmental services, which encompass infection prevention support, patient transport, housekeeping, and linen services to over 100 hospitals spread across more than 25 states. Since acquiring Xanitos in 2021, Angeles has closely collaborated with the management to enhance commercial strategies, expand business reach, optimize cost structures, and grow service offerings through mergers and acquisitions.
Under Angeles' stewardship, Xanitos experienced significant growth, with revenue doubling and the frontline workforce expanding. The firm’s efforts to fortify relationships with healthcare systems, broaden the leadership team, and invest in the workforce were pivotal in preparing the company for sustained long-term growth. Frank Spelman, Managing Director at Angeles, expressed pride in Xanitos’ transformation and its strong positioning for future profitability.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
In the United States, the healthcare sector is undergoing a paradigm shift, with an increasing focus on enhanced patient care and operational efficiency. As hospitals and healthcare providers grapple with rising costs and a demand for high-quality service deliver
Similar Deals
Bambu Ventures → Lemonaid Health
2026
Heartland Dental → Smile Design Dentistry
2025
Sun Pharmaceutical Industries Limited → Checkpoint Therapeutics, Inc.
2025
Court Square Capital and WindRose Health Investors → Soleo Health
2025
Patient Square Capital → Premier, Inc.
2025
Supernus Pharmaceuticals, Inc. → Sage Therapeutics, Inc.
2025
Bessemer Investors, LLC
invested in
Xanitos Inc.
in 2025
in a Buyout deal